The Illinois EPA has scheduled a formal public meeting to accept oral comments on a draft construction permit to place significant new controls on emissions at the Sterigenics US, LLC facility, located at 7775 Quincy Street in Willowbrook. The Illinois EPA has reviewed the construction permit application and has prepared a draft permit for public review. The formal public meeting will be held on August 1, 2019 from 6:00pm to 9:00pm at Ashton Place, 341 75th Street in Willowbrook. See the Documents and Links
On July 17, 2019, the Illinois Attorney General’s office and the DuPage County State’s Attorney’s office, in consultation with the Illinois Environmental Protection Agency, filed a consent order that provides strict, enforceable requirements on Sterigenics. Under the consent order, Sterigenics must meet those requirements in order to resume sterilization operations. Should Sterigenics fail to comply with the consent order, the company will be subject to penalties and contempt of court. The consent order, additional information and a Frequently Asked Questions document may be found in the Documents and Links
section below. For questions about the proposed consent decree, please contact the Illinois Attorney General’s office at http://www.illinoisattorneygeneral.gov/about/email_ag.jsp
Ethylene oxide (C2H4O)
Ethylene oxide is a flammable, colorless gas. It is produced and used to make a range of products, including antifreeze, textiles, plastics, detergents and adhesives. Ethylene oxide also is used to sterilize some medical equipment that cannot otherwise be sterilized by steam, ultraviolet light or other means, such as certain plastic and electronic devices. Ethylene oxide is also emitted in extremely small amounts from combustion of fuels.
The Clean Air Act lists ethylene oxide as a hazardous air pollutant (HAP). The Clean Air Act requires the USEPA to regulate hazardous air pollutants from categories of industrial facilities. In December 2016, U.S. EPA updated its
Integrated Risk Information System (IRIS) value for ethylene oxide.
Sterilization of medical devices is an essential aspect of modern medicine. There are several technologies to sterilize medical products and devices; however, many medical devices are sterilized using ethylene oxide because they have plastic parts or instrumentation that can be damaged by the steam, high heat or radiation of alternatives. The
Food and Drug Administration (FDA) regulates the sterilization of medical devices such that medical providers have a supply of sterilized medical devices. While the FDA has stated that it will be studying alternatives to ethylene oxide sterilization, it has not identified potential alternatives for near term approval.
Statutory and Regulatory Background
Since passage of the federal Clean Air Act (CAA) in 1970, there have been enormous reductions in emissions and corresponding improvements to ambient air quality. The original CAA focused on common air pollutants, some of which, such as ozone and particulate matter, were potentially causing acute health problems in certain parts of the country.
With passage of the 1990 Amendments to the CAA, USEPA began to set emission standards for hazardous air pollutants (HAP). Since that time, total emissions of hazardous air pollutants have declined. These National Emission Standards for Hazardous Air Pollutants (NESHAP) are technology-based standards to reduce HAP emissions from specific industries. The NESHAP for commercial sterilization plants was adopted in 1994, requiring control equipment to be added to commercial sterilizers reducing ethylene oxide emissions. NESHAPs are meant to be revisited by USEPA on a periodic basis to incorporate new science on hazardous air pollutants.
USEPA revisited the public health science and has published a new Integrated Risk Information System (IRIS) value for ethylene oxide in December 2016. IRIS data is a used by USEPA in evaluating risk of HAPs. With the new IRIS value for ethylene oxide, the USEPA began to review sources of ethylene oxide emissions including commercial sterilization facilities and performed dispersion modeling of the facilities nationwide. In reviewing the modeling and comparing to the IRIS value, certain facilities showed a higher than acceptable risk value at which further control of emissions is appropriate. USEPA typically regards a chronic risk (lifetime) of more the 1 in 10,000 to be higher than acceptable.
The USEPA released this information to states and the public in August 2018 with the release of the most recent National Air Toxics Assessment. USEPA is moving forward with
revising the NESHAP for commercial sterilization facilities in light of this information.
Permitting and Regulation of Stationary Sources
Among other things, the Illinois EPA enforces federal and state air pollution control laws and rules including NESHAP standards. One way Illinois EPA does so is with permitting of emitting facilities. This includes permitting of commercial sterilization facilities such as the Medline facility in Waukegan and the Sterigenics facility in Willowbrook. The Illinois EPA takes seriously its statutory mandate to protect ambient air quality.
Since the release by USEPA of the National Air Toxics Assessment and subsequent ambient monitoring data for Willowbrook, the Illinois EPA has been evaluating sources of ethylene oxide emissions including those in Lake County. The Agency has devoted a great deal of time and resources to understanding the issues around ethylene oxide including the location, emissions, air quality contribution, and existing and potential additional control measures for sources of ethylene oxide.
Although revised federal standards (NESHAPs) for ethylene oxide have not yet been proposed by the USEPA; at this time, the USEPA is working to that end.
Separately, the Illinois EPA is requiring facilities to take actions to reduce their ethylene oxide emissions to be protective of ambient air quality.
On May 30, 2019, the Illinois General Assembly passed Senate Bills 1854 and 1852 addressing sources of ethylene oxide emissions. Governor Pritzker signed these two bills into law, as
Public Act 101-0022 and
Public Act 101-0023 respectively, on June 21, 2019 with an immediate effective date.
Medline Industries is a commercial sterilizer located at 1160 Northpoint Boulevard in Waukegan. Medline uses ethylene oxide to sterilize medical equipment and devices. The facility currently operates under a federally enforceable state operating (FESOP) permit. As required by the current NESHAP, Medline has emission control equipment that controls ethylene oxide from the chambers where sterilization occurs and the rooms where the sterilized devices are aerated.
To address its ethylene oxide emissions, Medline has applied for and the Illinois EPA has issued a construction permit to the facility. The construction permit may be found in the Documents and Links section below. Under the construction permit, Medline will install several new emission controls, place the building under 100% capture (negative air pressure) and route all emissions through control devices. The construction permit includes performance requirements for the control devices and a limit on emissions from the facility of 150 pounds per year. Additionally, the permit requires a state of the art emissions monitor to be installed and a stack test to be performed to verify compliance. The measures set forth in the permit go well beyond measures required under the current NESHAP Subpart O.
These actions will significantly reduce the emissions and impact from Medline. The annual emission limit being established in the permit is set at the current level of detection for monitoring but actual emissions from the facility are expected to be lower. Dispersion modeling for Medline with these changes has been performed. The modelling has shown that with these changes, Medline's impact is far below USEPA’s reference 1 in 10,000 risk level.
The Illinois EPA held a public meeting in Waukegan to answer questions related to the planned issuance of the permit to Medline. The meeting was held on May 23, 2019 at Whittier Elementary School in Waukegan.
On May 30, 2019, the Illinois EPA issued construction permit 19020013 to Medline to install the controls and monitoring described above.
The Illinois EPA will continue to update this website to provide information on progress related to Medline.
If you have questions about Medline, please submit them to
Vantage Industries is a chemical manufacturer. The facility uses ethylene oxide in the manufacture of household and industrial products.
Vantage has installed additional pollution control devices at its facility and has committed to performing ambient air monitoring around its facility.
The Illinois EPA will shortly be scheduling a meeting in Gurnee to discuss a permitting transaction addressing the above measures among other actions at the facility. When a meeting is scheduled Illinois EPA will be making an announcement and reaching out locally to notify residents. You can also check back here for updated information.
Sterigenics is a commercial sterilizer operating out of two buildings, Willowbrook I and Willowbrook II, located at 7775 Quincy Street and 830 Midway in Willowbrook. The facilities are a single source for purposes of air permitting. Sterigenics uses ethylene oxide to sterilize medical equipment and devices. The facility currently operates under a Clean Air Act Permit Program (CAAPP) permit. As required by the current NESHAP, Sterigenics has emission control equipment that controls ethylene oxide from the chambers where sterilization occurs and the rooms where the sterilized devices are aerated. Additionally, Sterigenics previously received a
construction permit from the Illinois EPA to control emissions from the facility backvents.
Following several months of consistently high monitoring data, on February 15, 2019, Illinois EPA Director John Kim issued a
Seal Order to Sterigenics preventing the commencement of any new sterilization cycles using ethylene oxide at Willowbrook I & II as of the date and time of the Seal Order.
On June 24, 2019, Sterigenics submitted an application, see the
Documents and Links section below, to the Illinois EPA for a construction permit for further enhancements at the Willowbrook I facility. The Illinois has reviewed the application to ensure it satisfies among other things SB 1852/Public Act 101-0022 and has prepared a draft construction permit.
The Illinois EPA has scheduled a formal public meeting in Willowbrook to accept oral comments on the draft construction permit for Sterigenics. The meeting will be held on August 1, 2019 from 6:00 pm to 9:00 pm at
341 75th Street
Willowbrook, IL 60527
The Illinois EPA will accept written comments concerning the draft permit until August 15, 2019. Written comments should be submitted to EPA.Sterigenics@illinois.gov by August 15, 2019.
Questions about the meetings, permitting or other issues related to these sources should be made to the appropriate mailbox above or to
Office of Community Relations
Media Inquiries should be directed to
Public Information Officer
Documents and Links
Issued Construction Permit 19020013
Draft Construction Permit
Sterigenics construction permit application - June 24, 2019
Consent Order Overview and Frequently Asked Questions
Executed Sterigenics Consent Order
Memorandum in Support of Motion to Enter Consent Order
Joint Motion to Enter Consent Order